Skip to main content
Vivesto logo

Vivesto — Investor Relations & Filings

Ticker · VIVE ISIN · SE0000722365 LEI · 5493003TZPR4B7QO9L49 ST Manufacturing
Open in API
Filings indexed 1,069 across all filing types
Latest filing 2019-09-15 Board/Management Inform…
Country SE Sweden
Listing ST VIVE

About Vivesto

https://www.vivesto.com/en/

Vivesto is a specialty pharmaceutical company focused on drug development in oncology. The company aims to provide new therapeutic options for patients suffering from hard-to-treat cancers where significant medical needs exist. Its research and development efforts are centered on creating innovative treatments and enhancing the intravenous delivery of established and novel drugs. The company's lead product is Apealea, a formulation of the cancer drug paclitaxel.

Recent filings

Filing Released Lang Actions
Valberedningens förslag till styrelse och revisor för Oasmia Pharmaceutical AB inför årsstämman 2019
Board/Management Information Classification · 95% confidence The document text is in Swedish and discusses the proposal from the Nomination Committee ('Valberedning') regarding the Board of Directors ('styrelse') and auditor ('revisor') ahead of the Annual General Meeting ('årsstämman') scheduled for September 26, 2019. It details proposed new and re-elected board members (Hege Hellström, Anders Härfstrand, Jörgen Olsson, etc.) and the proposed auditor (KPMG). This content directly relates to the composition of the board and governance structure, which falls under Board/Management Information (MANG) or Governance Information (CGR). Since the primary focus is on the nomination/election of directors and auditors for the upcoming AGM, it is most accurately classified as Board/Management Information (MANG), as it announces changes/proposals for management/board roles. It is not a full AGM presentation (AGM-R) or a proxy statement (PSI), but rather the announcement of the committee's proposal.
2019-09-15 Swedish
Valberedningens förslag till styrelse och revisor för Oasmia Pharmaceutical AB inför årsstämman 2019
AGM Information Classification · 98% confidence The document is a press release dated September 17, 2019, titled "Valberedningens förslag till styrelse och revisor för Oasmia Pharmaceutical AB inför årsstämman 2019" (The Nomination Committee's proposal for the Board of Directors and Auditor for Oasmia Pharmaceutical AB ahead of the 2019 Annual General Meeting). It details the committee's proposals for new and re-elected board members and the proposed auditor, along with biographical information for the candidates. This content directly relates to the composition of the Board of Directors and management structure, which aligns perfectly with the definition for Board/Management Information (MANG). Although it mentions the AGM date, the core subject is the nomination committee's proposal for board members, not the AGM materials themselves (AGM-R) or voting results (DVA).
2019-09-15 Swedish
The Nomination Committee's proposal regarding Board of Directors and auditor of Oasmia Pharmaceutical AB for AGM 2019
Board/Management Information Classification · 99% confidence The document is a press release dated September 17, 2019, detailing the proposal made by the Nomination Committee regarding the Board of Directors and the auditor for the upcoming Annual General Meeting (AGM) scheduled for September 26, 2019. This content directly relates to the composition of the board and the election process for the AGM. While it discusses board members (Management Information - MANG) and auditors (Audit Information - AR), the context is explicitly tied to the proposals being presented *for* the AGM. The most specific category covering materials presented or related to the Annual General Meeting is 'AGM Information' (AGM-R).
2019-09-15 English
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 3,000 characters) that explicitly states the company's annual report is now available on their website and provides a download link under an 'Attachment' section. According to the 'Menu vs Meal' rule, an announcement stating that a report has been published or is attached is classified as a Report Publication Announcement (RPA).
2019-09-05 English
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 3,000 characters) that explicitly states the company's annual report is now available on their website and provides a download link under an 'Attachment' section. According to the 'Menu vs Meal' rule, an announcement stating that a report has been published or is attached is classified as a Report Publication Announcement (RPA).
2019-09-05 English
Oasmia offentliggör årsredovisning och reviderar räkenskaper efter nedskrivningar - revisor avstyrker beviljandet av ansvarsfrihet för tidigare styrelse
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 2,600 characters) stating that the company's annual report (årsredovisning) for 2018/2019 is now available on their website. It includes a link to the report as an attachment. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the annual report itself.
2019-09-05 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.